银屑病与新冠病毒感染相互产生负面影响：3581例病例分析
Psoriasis and COVID-19 Infection Negatively Impact Each Other: An Analysis of 3581 Cases.
作者信息
Wang Xiaohua, Yuan Liyan, Qiu Xiaoyu, Yang Bin, Man Mao-Qiang
机构信息
Dermatology Hospital, Southern Medical University, Guangzhou, People's Republic of China.
出版信息
Clin Cosmet Investig Dermatol. 2023 Jul 25;16:1933-1936. doi: 10.2147/CCID.S421394. eCollection 2023.
Abstract
OBJECTIVE
To determine whether COVID-19 infection and psoriasis impact each other.
METHODS
WeChat app was used to carry out a questionnaire survey in individuals aged 18 years and over.
RESULTS
A total of 3581 individuals, including 2515 individuals without psoriasis and 1066 psoriatic patients completed the survey. The rate of COVID-19 infection was significantly higher in psoriatic patients than in those without psoriasis (89.59% vs 77.93%, p < 0.0001). Moreover, the rate of relapse and/or worsening of psoriasis was higher in psoriatic patients with COVID-19 infection than in that without COVID-19 infection (75.29% vs 47.75%, p < 0.0001).
CONCLUSION
COVID-19 infection and psoriasis negatively impact each other.
摘要
目的
确定新型冠状病毒肺炎（COVID-19）感染与银屑病是否相互影响。
方法
通过微信应用程序对18岁及以上人群进行问卷调查。
结果
共有3581人完成调查，其中2515人无银屑病，1066人为银屑病患者。银屑病患者的COVID-19感染率显著高于无银屑病者（89.59%对77.93%，p<0.0001）。此外，感染COVID-19的银屑病患者中银屑病复发和/或加重的发生率高于未感染COVID-19的患者（75.29%对47.75%，p<0.0001）。
结论
COVID-19感染与银屑病相互产生负面影响。
相似文献
1
Psoriasis and COVID-19 Infection Negatively Impact Each Other: An Analysis of 3581 Cases.银屑病与新冠病毒感染相互产生负面影响：3581例病例分析
Clin Cosmet Investig Dermatol. 2023 Jul 25;16:1933-1936. doi: 10.2147/CCID.S421394. eCollection 2023.
2
Effect of Lockdown Due to COVID-19 on Health and Lifestyle of Psoriasis Patients: A Web-Based Survey.2019年冠状病毒病封锁措施对银屑病患者健康和生活方式的影响：一项基于网络的调查
Indian Dermatol Online J. 2022 Sep 5;13(5):625-628. doi: 10.4103/idoj.idoj_46_22. eCollection 2022 Sep-Oct.
3
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies.COVID-19 大流行对意大利接受生物疗法治疗的银屑病患者队列的影响。
J Dermatolog Treat. 2022 Mar;33(2):1079-1083. doi: 10.1080/09546634.2020.1800578. Epub 2020 Aug 4.
4
COVID-19 and psoriasis: biologic treatment and challenges.COVID-19 与银屑病：生物治疗及挑战
J Dermatolog Treat. 2022 Mar;33(2):699-703. doi: 10.1080/09546634.2020.1789051. Epub 2020 Jul 6.
5
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study.意大利 COVID-19 大流行期间接受生物制剂治疗的慢性斑块型银屑病患者的特征：来自 PSO-BIO-COVID 观察性研究的风险分析。
Expert Opin Biol Ther. 2021 Feb;21(2):271-277. doi: 10.1080/14712598.2021.1853698. Epub 2021 Jan 13.
6
Psoriasis Flares in Patients With COVID-19 Infection or Vaccination: A Case Series.新型冠状病毒肺炎感染或接种疫苗患者的银屑病发作：病例系列
Cureus. 2022 Jun 16;14(6):e25987. doi: 10.7759/cureus.25987. eCollection 2022 Jun.
7
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.银屑病患者认知的演变：利用治疗见解了解银屑病（UPLIFT）调查结果
Dermatol Ther (Heidelb). 2022 Jan;12(1):61-78. doi: 10.1007/s13555-021-00635-4. Epub 2021 Oct 25.
8
COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain.西班牙北部接受生物免疫抑制剂治疗的 COVID-19 合并银屑病和银屑病关节炎患者与接受阿普米司特治疗患者的比较。
Dermatol Ther. 2020 Nov;33(6):e13961. doi: 10.1111/dth.13961. Epub 2020 Jul 27.
9
[BIOLOGICAL TREATMENT OF PSORIASIS IN TIME OF NEW CORONAVIRUS INFECTION COVID-19].[新型冠状病毒感染COVID-19期间银屑病的生物治疗]
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2021 Aug;29(Special Issue):1381-1387. doi: 10.32687/0869-866X-2021-29-s2-1381-1387.
10
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment.羟氯喹对银屑病的作用：系统评价及对 COVID-19 治疗的警示。
J Am Acad Dermatol. 2020 Aug;83(2):579-586. doi: 10.1016/j.jaad.2020.05.074. Epub 2020 May 19.
引用本文的文献
1
Current treatment of Psoriasis triggered by Cytokine Storm and future immunomodulation strategies.细胞因子风暴诱发银屑病的治疗现状与未来免疫调节策略
J Mol Med (Berl). 2024 Oct;102(10):1187-1198. doi: 10.1007/s00109-024-02481-1. Epub 2024 Aug 30.
2
Risk Factors for Psoriasis Flares: A Narrative Review.银屑病发作的危险因素：一篇叙述性综述。
Psoriasis (Auckl). 2024 May 30;14:39-50. doi: 10.2147/PTT.S323281. eCollection 2024.
本文引用的文献
1
New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series.新型冠状病毒感染或接种疫苗后新发及复发的银屑病经生物制剂成功治疗：病例系列
J Dermatolog Treat. 2023 Dec;34(1):2198050. doi: 10.1080/09546634.2023.2198050.
2
Clinical course of psoriasis patients that discontinued biologics during the COVID-19 pandemic.在新冠疫情期间停用生物制剂的银屑病患者的临床病程。
J Cosmet Dermatol. 2023 Mar;22(3):722-731. doi: 10.1111/jocd.15638. Epub 2023 Jan 11.
3
Case report: Clinical features of COVID-19 vaccine-induced exacerbation of psoriasis-A case series and mini review.病例报告：新冠病毒疫苗诱发银屑病加重的临床特征——病例系列及简要综述
Front Med (Lausanne). 2022 Sep 26;9:995150. doi: 10.3389/fmed.2022.995150. eCollection 2022.
4
How COVID-19 shaped mental health: from infection to pandemic effects.新冠疫情如何影响心理健康：从感染到大流行的影响。
Nat Med. 2022 Oct;28(10):2027-2037. doi: 10.1038/s41591-022-02028-2. Epub 2022 Oct 3.
5
Psoriasis Flares in Patients With COVID-19 Infection or Vaccination: A Case Series.新型冠状病毒肺炎感染或接种疫苗患者的银屑病发作：病例系列
Cureus. 2022 Jun 16;14(6):e25987. doi: 10.7759/cureus.25987. eCollection 2022 Jun.
6
Roles of Infection in Psoriasis.感染在银屑病中的作用。
Int J Mol Sci. 2022 Jun 23;23(13):6955. doi: 10.3390/ijms23136955.
7
Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry).儿童银屑病与 COVID-19：与 COVID-19 不良病程相关的因素，以及感染对疾病进展的影响（Chi-PsoCov 登记处）。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):2076-2086. doi: 10.1111/jdv.18361. Epub 2022 Jul 6.
8
A nationwide population-based cohort study of the incidence of severe and rare infections among adults with psoriasis in Denmark.一项针对丹麦成年人银屑病严重和罕见感染发生率的全国性基于人群的队列研究。
Br J Dermatol. 2022 Sep;187(3):353-363. doi: 10.1111/bjd.21595. Epub 2022 May 22.
9
Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments.通过阻断IL-17信号传导可降低银屑病皮损中SARS-CoV-2受体ACE2的表达，但其他生物治疗方法则无此效果。
J Am Acad Dermatol. 2022 Sep;87(3):714-715. doi: 10.1016/j.jaad.2022.01.041. Epub 2022 Jan 29.
10
Risk of infections in psoriasis: assessment and challenges in daily management.银屑病患者的感染风险：评估及日常管理中的挑战。
Expert Rev Clin Immunol. 2021 Nov;17(11):1211-1220. doi: 10.1080/1744666X.2021.1997592. Epub 2021 Nov 1.
Zotero 插件